Published in Biotech Law Weekly, February 23rd, 2007
A nucleic acid, 2-5AN6B inhibited HIV replication in white blood cells from a group of 18 HIV infected patients by up to 80%, regardless of the patients' treatment regimens.
"A cure for HIV infection remains an elusive goal despite the significant impact of current treatments because of the virus'...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.